Latest Posts › Compliance

Share:

How Life Sciences Companies Can Create a Culture of Compliance When Expanding to the U.S. Market [Audio]

In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by David Blank, AGG Healthcare partner, to discuss how foreign life sciences companies can proactively address...more

New U.S. Tariffs on Goods From Canada, China, and Mexico Take Effect February 1

Effective February 1, 2025, the U.S. will impose new tariffs on imported goods, significantly impacting businesses engaged in cross-border trade. The tariffs include: While these tariffs apply broadly to all goods from these...more

Bureau of Industry and Security Issues New Guidance to Financial Institutions on Best Practices for Export Administration...

In October 2024, the Bureau of Industry and Security (“BIS”) issued new guidance to financial institutions (“FIs”) on best practices for compliance with the Export Administration Regulations (“EAR”). This guidance outlines...more

Quality Agreements: An AGG Podcast Recap

A few weeks ago, AGG’s Food and Drug Practice Team launched its podcast series to discuss topics affecting the FDA-regulated industry. The series, called “I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues,”...more

Novartis’ FCPA Settlement and New Compliance Guidance

In late June, the U.S. Department of Justice (“DOJ”) and Securities and Exchange Commission (“SEC”) announced that Novartis AG and Alcon Pte Ltd, a former subsidiary of the Swiss drug maker, agreed to pay a combined $347...more

Prime(d) for Export Control Compliance?

On July 8, 2020, the U.S. Department of Treasury’s Office of Foreign Assets Control (“OFAC”) announced a $134,523 civil settlement with Amazon, Inc. (“Amazon”), for alleged violations of multiple OFAC sanction and embargo...more

AGG's CARES Act Webinar [Video]

As we continue to learn more about the Coronavirus Aid, Relief and Economic Security Act (CARES Act), we are committed to sharing our knowledge and understanding of the bill with our clients. In this webinar, we provided a...more

Mitigating Fraud and Corruption Risks During the COVID-19 Crisis

Fraud and corruption thrive in chaos. The COVID-19 pandemic and its economic destabilization create the conditions in which misconduct can thrive....more

Guidance on Effective Self-Disclosure of FCPA Violations for Life Sciences Companies

Every life sciences company with international operations should have a robust Foreign Corrupt Practices Act (FCPA) compliance program as part of its overall compliance strategy. On April 5, 2016, the Justice Department...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide